- Home
- FLUX vs MIRA Comparison
FLUX vs MIRA Comparison
Compare FLUX & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- MIRA
- Stock Information
- Founded
- FLUX N/A
- MIRA 2020
- Country
- FLUX United States
- MIRA United States
- Employees
- FLUX N/A
- MIRA N/A
- Industry
- FLUX Industrial Machinery/Components
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- MIRA Health Care
- Exchange
- FLUX Nasdaq
- MIRA Nasdaq
- Market Cap
- FLUX 30.0M
- MIRA 26.5M
- IPO Year
- FLUX N/A
- MIRA 2023
- Fundamental
- Price
- FLUX $2.78
- MIRA $1.29
- Analyst Decision
- FLUX Strong Buy
- MIRA Strong Buy
- Analyst Count
- FLUX 2
- MIRA 1
- Target Price
- FLUX $6.00
- MIRA $17.00
- AVG Volume (30 Days)
- FLUX 581.6K
- MIRA 804.3K
- Earning Date
- FLUX 09-16-2025
- MIRA 11-11-2025
- Dividend Yield
- FLUX N/A
- MIRA N/A
- EPS Growth
- FLUX N/A
- MIRA N/A
- EPS
- FLUX N/A
- MIRA N/A
- Revenue
- FLUX $66,434,000.00
- MIRA N/A
- Revenue This Year
- FLUX $10.96
- MIRA N/A
- Revenue Next Year
- FLUX $12.78
- MIRA N/A
- P/E Ratio
- FLUX N/A
- MIRA N/A
- Revenue Growth
- FLUX N/A
- MIRA N/A
- 52 Week Low
- FLUX $1.15
- MIRA $0.73
- 52 Week High
- FLUX $3.39
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- FLUX 71.28
- MIRA 40.50
- Support Level
- FLUX $1.47
- MIRA $1.19
- Resistance Level
- FLUX $3.31
- MIRA $1.72
- Average True Range (ATR)
- FLUX 0.25
- MIRA 0.10
- MACD
- FLUX 0.15
- MIRA -0.01
- Stochastic Oscillator
- FLUX 71.47
- MIRA 18.25
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.